Actavis launches generic olanzapine in four European countries
This article was originally published in Scrip
Actavis launched generic olanzapine (Lilly's treatment of schizophrenia and bipolar disorder Zyprexa) in Bulgaria, Hungary, Slovakia and Spain immediately after Lilly's patents expired in these countries on 24 April. It may launch Olanzapine Actavis also in other European countries in September when the patents expire there.
You may also be interested in...
Poland's president, Bronislaw Komorowski, has signed a reimbursement bill into the law which will come into force on 1 January.
In the past two years, most multinational pharmaceutical companies announced plans to create production facilities in Russia. They had been ignoring such an opportunity for years, and there were reasons for that. They included risks to investments, administrative barriers, unclear regulations assuming various interpretations and corruption.
Russia's president Dmitriy Medvedev has requested that his government start talks with the US and the EU on the mutual recognition of clinical trial results (including paediatric trials) and prepare proposals for corresponding amendments of existing regulations.